Washington Wire: May 2019

Featured Story: CMS decides against allowing Medicare plans to limit coverage of “protected class” drugs. This past month brought some welcome news from the U.S. Centers for Medicare and Medicaid Services. On May 16, CMS released a final rule on drug pricing in the Medicare Advantage and Medicare Part D programs. In that final rule, […]